Reported Earlier: Sandoz Canada Launches Lower-Cost Generic Version Of Novo Nordisk’s Ozempic, Expanding Access to Semaglutide for Type 2 Diabetes
PrSandoz® Semaglutide, a generic version of PrOzempic®, approved for the treatment of adult patients with type 2 diabetesThis lower-cost alternative supports improved affordability and access to type 2 diabetes
A company called Sandoz made a cheaper copy of a popular diabetes medicine. When cheaper versions exist, the original company might sell less medicine or lower prices.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.